See also this year's filing and all EDGAR filings for this company.
PDF Report 0001587221_2021_Zosano_Pharma_Corp.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001587221, Zosano Pharma Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 35,716,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 30,909,000 |
| 3 | remainder_Assets | 5,386,000 |
| 4 | LiabilitiesCurrent | 14,511,000 |
| 5 | LiabilitiesNoncurrent | 5,626,000 |
| 6 | remainder_Liabilities | 4,359,000 |
| 7 | CostOfGoodsAndServicesSold | 171,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,189,000 |
| 9 | ResearchAndDevelopmentExpense | 21,622,000 |
| 10 | remainder_Expenses | 719,000 |
| 11 | remainder_Revenues | 224,000 |
| 12 | remainder_NetIncome | 108,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 72,011,000 |
| 1 | Liabilities | 24,496,000 |
| 2 | Expenses | 33,701,000 |
| 3 | Revenues | 224,000 |
| 4 | StockholdersEquity | 47,515,000 |
| 5 | NetIncome | -33,369,000 |
| 6 | ComprehensiveNetIncome | -33,369,000 |
| 7 | BaseVar | 65,270,000 |
| 8 | EconomicCapitalRatio | 1.00 |
Edgar->Model Mapping
Feature Distribution
Change over Time
